|
|
Dren Bio announces strategic collaboration with Novartis
Dren Bio, one of our distinguished alumni, has announced a strategic collaboration with Novartis to develop bispecific antibody therapies targeting cancer. This partnership, which builds on Dren Bio’s targeted myeloid engager and phagocytosis platform, includes an upfront payment of $150 million from Novartis, with $25 million as an equity investment.
MBC BioLabs is proud to have helped Nenad Tomasevic launch Dren Bio in 2020 with lab space at our 733 Industrial Rd. campus and seed financing from Mission Bay Capital. Congratulations to the whole team and we can't wait to see what you accomplish next.
► READ MORE
|
|
Montara Therapeutics announces $8M seed round
Montara Therapeutics has launched with $8 million in seed funding to develop a “BrainOnly” platform, designed to target central nervous system (CNS) disorders while minimizing peripheral side effects. Montara's initial program will improve upon a molecule with proven clinical efficacy that is limited by severe peripheral side effects. We are excited that the great team behind Mitokinin is back with a second company at MBC BioLabs, and we look forward to seeing Montara’s future progress and success.
► READ MORE
|
|
Nitto Golden Ticket 2024
MBC BioLabs, in partnership with Nitto Innovations, Inc., is excited to announce the 2024 Golden Ticket Competition, aimed at catalyzing innovation in clean tech and climate tech. Nitto is particularly interested in hydrogen, energy storage, carbon capture, material innovation, and recycling technologies.
► APPLY UNTIL AUGUST 9
|
|
|
BMS Golden Ticket
The Bristol Myers Squibb Golden Ticket Contest at MBC BioLabs is a contest that awards two laboratory bench spots to two innovative biotech start-ups pursuing research in the fields of oncology, hematology, immunoscience, cardiovascular disease, neuroscience or fibrotic diseases.
► APPLY UNTIL AUGUST 9
|
|
|
Eisai Golden Ticket
Eisai Innovation, Inc., is interested in drug discovery platform technologies, novel targets and biology that can be utilized in oncology and neurology.
► APPLY UNTIL AUGUST 30
|
|
|
ONO Golden Ticket Winner
ONO and MBC BioLabs are delighted to announce DeepSeq.AI as the winner of their 2024 Golden Ticket Competition.
DeepSeq.AI uses its custom AI platform to enable pharmaceutical companies to develop highly novel, functional, and manufacturable large molecule drugs, using an explainable generative AI-based approach that optimizes multiple functions with proprietary large-scale wet-lab screening methods.
► READ MORE
|
|
|
Lunch & Learn with Agilent
August 7 @ noon - 1pm
733 Industrial Rd, San Carlos
Learn more about the Agilent Novocyte Penteon flow cytometer at this interactive lunch and learn with Agilent Product Specialist Lisa Salow. The Agilent Novocyte is available in our cores at 733 Industrial Road, San Carlos.
► REGISTER
|
|
|
Lunch & Learn with Agilent Cell Analysis
August 14 @ noon - 1pm
135 Mississippi St, San Francisco
Get a 360 view of your cells with the suite of Agilent Cell Analysis instrumentation, including imaging with Cytation, metabolic profiling with Seahorse, and flow cytometry with Novocyte, all available in our cores.
► REGISTER
|
|
|
Fisher Scientific Vendor Show
August 8 @ noon - 2pm
930 Brittan Ave, San Carlos
Please join our partners at Fisher Scientific for their 2024 Vendor Show - Get to meet team members from Fisher Scientific, Biocom, Eppendorf, Sartorius, Corning, Cytiva, and Thermo Fisher Scientific's Laboratory Products and Life Sciences division and enjoy free lunch!
► READ MORE
|
|
|
Founders at Work: Siolta Therapeutics
August 15 @ noon - 1pm
930 Brittan Ave, San Carlos
Please join us for a Fireside Chat featuring Siolta Therapeutics’ Founder and CEO, Nikole Kimes, and CSO, Ricardo Valladares.
Siolta Therapeutics is advancing live biotherapeutic products (LBPs) and currently conducting a prevention study to develop the first LBP for infants.
► REGISTER
|
|
|
Summer BBQ Bash with JLABS
August 21 @ 11:30am - 1pm
135 Mississippi St, San Francisco
Join us and our partners at JLABS for an unforgettable summer BBQ! Don't miss out on this fantastic opportunity to mingle and make lasting connections. Grab a plate, soak up the atmosphere, and have a sizzling good time!
► REGISTER
|
|
|
Lunch & Learn with Telesis Bio
August 21 @ noon - 1pm
930 Brittan Ave, San Carlos
Please join our partners at Telesis Bio for lunch & learn about the BioXp synthetic and molecular biology workstation that can synthesize genes, assemble and amplify clones as well as build DNA variant libraries and synthetic mRNA in a single overnight run, located in our core at 733 Industrial Road, San Carlos.
|
|
|
Agilent Solutions Showcase Casino Party
August 22 @ 1 - 3pm
930 Brittan Ave, San Carlos
Get ready to roll the dice and hit the jackpot of networking opportunities! Join our partners at Agilent for an electrifying Casino Summer themed event and mingle with Agilent representatives from their Chromatography and Spectrometry, Genomics, Spectroscopy, Cell Analysis, and Financial Solutions divisions.
► REGISTER
|
|
|
Life Science Vendor's Showcase
August 27 @ 10am - 2pm
135 Mississippi St, San Francisco
We are thrilled to invite you to our upcoming Life Science Vendor Showcase! This exciting event will feature the latest and most innovative life science technologies and services from a diverse range of vendors. Lunch will be available.
► REGISTER
|
|
|
Spaero Kick-Off Event
August 28 @ noon - 1pm
733 Industrial Rd, San Carlos
We are excited to announce our partnership with Spaero Bio, which brings the Hamilton Microlab Prep to our cores in San Carlos! Join us for a kick-off event to meet the Spaero team and learn more about their instrument.
|
|
|
Malvern Panalytical: Small Molecule Development Workshop
September 24 @ 9:30am - 3:30pm
135 Mississippi St, San Francisco
Struggling with small molecule development post discovery? Come learn from our partners at Malvern Panalytical on how these challenges can be addressed!
► REGISTER
|
|
|
Partner Office Hours
Connect with our partners from Cytiva, Malvern Panalytical, Agilent, Eppendorf, Revvity, or MilliporeSigma during their scheduled office hours this month!
► CHECK THE CALENDAR
|
|
|
Adjuvia
Adjuvia is developing novel therapeutics to address diseases that arise from mitochondrial and cellular dysfunction. Adjuvia’s lead compound, ATI-103, is a proprietary formulation of astaxanthin, a powerful antioxidant that protects cells from harmful reactive oxygen species (ROS) produced during mitochondrial energy production, and regulates many cell signaling pathways important for immune function and metabolic homeostasis.
We warmly welcome Co-founder and CEO, Laura Glickman and Scientist, Naveed Ziari to the 953 Indiana community in San Francisco!
► READ MORE
|
|
|
LifeActive
LifeActive is a biomaterials company that develops and licenses a medically beneficial transdermal delivery platform (TDP). The TDP provides both business and delivery advantages for partnering pharmaceutical companies.
Welcome, Scott Jenkins, to the 733 Industrial Road community in San Carlos!
► READ MORE
|
|
|
SPECIAL THANKS TO OUR PARTNERS
|
|
|
|
|
|
MBC BioLabs - Enabling Awesome
|
|
|
|
|
|